Literature DB >> 17435195

Guillain-Barré syndrome with antibodies to GD1a/GD1b complex.

Tsuyoshi Hamaguchi, Kenichi Sakajiri, Kenji Sakai, Soichi Okino, Masami Sada, Susumu Kusunoki.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17435195      PMCID： PMC2117836          DOI： 10.1136/jnnp.2006.108217

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Anti-ganglioside complex antibodies in Miller Fisher syndrome.

Authors:  K Kaida; M Kanzaki; D Morita; K Kamakura; K Motoyoshi; M Hirakawa; S Kusunoki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-13       Impact factor: 10.154

2.  Ganglioside complexes as new target antigens in Guillain-Barré syndrome.

Authors:  Ken-ichi Kaida; Daiji Morita; Mami Kanzaki; Keiko Kamakura; Kazuo Motoyoshi; Minako Hirakawa; Susumu Kusunoki
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

3.  N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome.

Authors:  S Kusunoki; A Chiba; K Kon; S Ando; K Arisawa; A Tate; I Kanazawa
Journal:  Ann Neurol       Date:  1994-05       Impact factor: 10.422

4.  Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial.

Authors:  R van Koningsveld; P I M Schmitz; F G Avander Meché; L H Visser; J Meulstee; P A van Doorn
Journal:  Lancet       Date:  2004-01-17       Impact factor: 79.321

5.  Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.

Authors:  T W Ho; B Mishu; C Y Li; C Y Gao; D R Cornblath; J W Griffin; A K Asbury; M J Blaser; G M McKhann
Journal:  Brain       Date:  1995-06       Impact factor: 13.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.